No matches

Pulmonology

ERS 2026 | Distal Airways, Central Role? Clinical Insights Into Type 2 Severe Asthma

Join experts Frederik Trinkmann, Monica Kraft, and Arnaud Bourdin on an ADVENT educational symposium, “Distal Airways, Central Role? Clinical Insights Into Type 2 Severe Asthma."

Monica Kraft +2 more

35 minutes

Related resources

CRSwNP at Center Stage: Impact of Biologics in Patients with Co-existing Type 2 Asthma

3 min

expert video

Corticosteroids in Asthma Management

3 min

Infographic

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients

3 min

Infographic

A view into the Airway: The Pathophysiology and Clinical Relevance of Mucus Plugs in Asthma

4 min

videoanimation

Lung Function Decline: Why it Matters and What’s at Stake for Patients

5 min

interactivity

Eosinophils: A Biomarker in COPD

5 min

Infographic

Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes

5 min

interactivity

Airway Hyperresponsiveness In Asthma Is Mainly Driven By Components Of Type 2 Inflammation

5 min

interactivity

ADVENT On Air | The Road Ahead: Achieving Remission for Patients With Asthma

24 min

Podcast

Uncovering the Impact of Moderate COPD Exacerbations

5 min

interactivity

ERS 2026 | Breaking Silos Between Asthma and CRSwNP: Loss of Smell as a Marker of Unified Airway Disease

35 min

expert video

Learning objectives

Highlight the complexity of small airways disease and the burden on patients with potentially normal spirometry
Educate on the role of type 2 inflammation in mucus plugging and airway remodeling
Explore the available clinical data from the current therapeutic landscape supporting the impact on mucus plugging and small airway patency

Description

Explore the importance of assessing small airway disease in asthma and the role of type 2 inflammation in mucus plugging and airway remodeling.

About these experts

Pulmonology

Monica Kraft

Murray M. Rosenberg Professor of Medicine and System Chair for the Department of Medicine | Mount Sinai Health, New York, United States

Pulmonology

Frederik Trinkmann

Frederik Trinkmann, MD, is an associate professor at Heidelberg University in Heidelberg, Germany. Additionally, he is an executive senior physician in the department of pulmonology and respiratory medicine and director of the Asthma Outpatient Clinic at the Thoraxklinik within Heidelberg University Hospital. Additionally, Professor Trinkmann serves as a research associate in the department of biomedical informatics in the Center for Preventative Medicine and Digital Health Baden-Württemberg at the University Medical Center Mannheim in Mannheim, Germany.

Pulmonology

MD, PhD

Arnaud Bourdin

Arnaud Bourdin, MD, PhD, is head of pulmonology and a professor of respiratory medicine at the University of Montpellier’s Arnaud de Villeneuve Hospital in Montpellier, France. He is an associate dean of the University of Montpellier’s faculty of medicine. He also acts as the leader of the Respiratory Diseases and the Environment research team at the Physiology & Experimental Medicine of the Heart and Muscles Laboratory. Professor Bourdin earned both his medical degree and PhD from the University of Montpellier, which he followed with a fellowship at Monash University in Melbourne, Australia.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: Czech RepublicChange country/region

ERS 2026 | Distal Airways, Central Role? Clinical Insights Into Type 2 Severe Asthma

Related resources

CRSwNP at Center Stage: Impact of Biologics in Patients with Co-existing Type 2 Asthma

Corticosteroids in Asthma Management

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients

The Burden in Patients with CRSwNP and Coexisting Asthma

Spotlight on Type 2 Inflammation in the Upper and Lower Airways

Compounded Burden of Co-existing Type 2 Airway Diseases

2025 ADVENT Forum | Remodeling in the Airway: A Damaged State of Affairs

2025 ADVENT Forum | Potential for Disease Modification in the Airway

A view into the Airway: The Pathophysiology and Clinical Relevance of Mucus Plugs in Asthma

Lung Function Decline: Why it Matters and What’s at Stake for Patients

Eosinophils: A Biomarker in COPD

Tailored Medicine in COPD: Understanding Phenotypes, Endotypes, and Genotypes

Airway Hyperresponsiveness In Asthma Is Mainly Driven By Components Of Type 2 Inflammation

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Uncovering the Impact of Moderate COPD Exacerbations

ERS 2026 | Breaking Silos Between Asthma and CRSwNP: Loss of Smell as a Marker of Unified Airway Disease

Learning objectives

Description

About these experts

Monica Kraft

Frederik Trinkmann

Arnaud Bourdin

ADVENT On Air | The Road Ahead: Achieving Remission for Patients With Asthma